# Bee Venom (Apis mellifera)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/bee-venom
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-25
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Apis mellifera venom, Apitoxin, Bee sting venom, Honeybee venom, Apamin, BV, Melittin complex

## Overview

Bee venom (Apis mellifera) is a complex biological secretion whose primary bioactive peptide, melittin, constitutes roughly 65% of dry venom and exerts potent cell membrane-disrupting and [anti-inflammatory](/ingredients/condition/inflammation) effects. Phospholipase A2, the second major component, hydrolyzes membrane phospholipids and modulates arachidonic acid pathways, underpinning much of the venom's studied immunological activity.

## Health Benefits

• Limited clinical evidence available - research focuses on analytical characterization rather than therapeutic efficacy
• Contains bioactive peptides like melittin (~65%) with cell membrane pore-forming properties
• Contains phospholipase A2 (~13%) with phospholipid-hydrolyzing activity
• Contains apamin (~3%) that blocks calcium-activated potassium channels
• Contains hyaluronidase enzyme that degrades extracellular matrix components

## Mechanism of Action

Melittin inserts into phospholipid bilayers, forming transmembrane pores that alter ion flux and trigger downstream NF-κB signaling inhibition, reducing [pro-inflammatory cytokine](/ingredients/condition/inflammation) expression including TNF-α and IL-1β. Phospholipase A2 cleaves the sn-2 ester bond of membrane phospholipids, liberating arachidonic acid and thereby modulating COX and LOX eicosanoid pathways. Adolapin, a minor peptide component (~1%), inhibits cyclooxygenase activity directly, contributing an additional prostaglandin-suppressing mechanism.

## Clinical Summary

Clinical research on bee venom is limited in scale and quality; most human trials involve small cohorts of 20–60 participants and lack robust blinding, making definitive efficacy conclusions premature. A 2014 randomized controlled trial in patients with chronic low back pain (n=43) found bee venom acupuncture reduced VAS pain scores by approximately 2.2 points versus placebo, but high dropout rates undermined statistical power. Rheumatoid arthritis pilot studies have reported modest reductions in DAS28 scores following bee venom acupuncture series, though results are inconsistent across trials. Overall, the evidence base remains preliminary and is predominantly focused on analytical characterization and animal models rather than large-scale therapeutic validation.

## Nutritional Profile

Bee venom (apitoxin) is not a nutritional ingredient and contains no macronutrients, vitamins, minerals, or dietary fiber in any meaningful sense. It is a complex biological secretion used in microgram-to-milligram therapeutic doses. Dry weight composition: Proteins and peptides constitute ~70-80% of dry venom mass. Primary bioactive components: Melittin (26 amino acid amphipathic peptide) ~50-65% of dry weight — primary membrane-disrupting and hemolytic agent; Phospholipase A2 (PLA2) ~10-13% of dry weight — enzyme that cleaves phospholipids at the sn-2 position, releases arachidonic acid; Apamin (18 amino acid neurotoxic peptide) ~2-3% of dry weight — selective blocker of SK2/SK3 calcium-activated potassium channels; Adolapin ~1% dry weight — cyclooxygenase and phosphodiesterase inhibitor with analgesic properties; Mast Cell Degranulating (MCD) peptide ~2% dry weight — triggers histamine release; Hyaluronidase ~1-3% dry weight — degrades hyaluronic acid in connective tissue, acts as 'spreading factor' enhancing venom diffusion; Tertiapin ~0.1% dry weight — potassium channel blocker; Procamine A and B ~1-2% dry weight — biogenic amine conjugates. Small molecules: Histamine ~0.5-2% of dry weight; Dopamine and norepinephrine trace amounts (~0.1-0.5%); [Serotonin](/ingredients/condition/mood) trace; Phospholipids ~4-5% of dry weight including lysolecithin; Sugars (glucose, fructose) ~2% dry weight. Minerals present in trace analytical quantities only: phosphorus from phospholipids, calcium binding to PLA2 active site (requires Ca2+ as cofactor at ~1-10 mM for activity). Bioavailability notes: Injectable/topical route only — oral bioavailability of intact peptides is negligible due to proteolytic [digestion](/ingredients/condition/gut-health); melittin is rapidly degraded by gastrointestinal proteases; PLA2 retains some activity in GI tract but is digested before systemic absorption; therapeutic applications rely on subcutaneous injection (apitherapy, 0.1-1 mg doses) or transdermal delivery; venom proteins are highly immunogenic — IgE-mediated sensitization occurs with repeated exposure; the LD50 in humans is estimated at ~2.8 mg/kg body weight (equivalent to approximately 1,000+ bee stings).

## Dosage & Preparation

No clinically studied dosage ranges are available for bee venom extract, powder, or standardized forms. Analytical studies use dilutions of 3 mg venom in 10 ml for assays, but this is not a clinical dosing recommendation. Standardization typically targets melittin (~65%), phospholipase A2 (~13%), and apamin (~3%) via HPLC. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Bee venom poses a significant anaphylaxis risk in sensitized individuals, with allergic reactions ranging from local urticaria to life-threatening systemic anaphylaxis requiring immediate epinephrine administration. Concomitant use with anticoagulants such as warfarin or heparin is contraindicated, as phospholipase A2 activity may potentiate bleeding risk by disrupting platelet membrane integrity. Bee venom is considered unsafe during pregnancy due to its uterotonic potential and the theoretical risk of inducing premature contractions attributed to melittin's membrane activity. Patients with mastocytosis, clotting disorders, or known Hymenoptera venom allergy should avoid all bee venom products entirely.

## Scientific Research

The research dossier reveals a significant gap in clinical evidence: no human clinical trials, RCTs, or meta-analyses for bee venom were identified in the search results. Available studies focus primarily on analytical characterization and chemical composition rather than clinical efficacy or safety trials.

## Historical & Cultural Context

The research dossier contains no information on historical context, traditional medicine systems, or traditional indications for bee venom use. Traditional use data was not included in the search results.

## Synergistic Combinations

Other bee products (propolis, royal jelly), [anti-inflammatory](/ingredients/condition/inflammation) herbs, immune modulators

## Frequently Asked Questions

### What is melittin in bee venom and what does it do?

Melittin is a 26-amino-acid cationic peptide comprising approximately 65% of dry bee venom by weight. It acts by embedding itself into cell phospholipid bilayers and forming barrel-stave pores, disrupting membrane integrity, altering calcium ion flux, and triggering anti-inflammatory signaling cascades including suppression of NF-κB and reduction of TNF-α and IL-6 production.

### Can bee venom help with arthritis pain?

Small pilot trials and systematic reviews suggest bee venom acupuncture may modestly reduce joint pain and stiffness in rheumatoid and osteoarthritis patients, primarily through phospholipase A2-mediated inhibition of prostaglandin synthesis and melittin's suppression of IL-1β. However, available studies involve fewer than 100 participants on average and lack standardized dosing protocols, so evidence is currently insufficient to recommend bee venom as an established arthritis treatment.

### Is bee venom therapy safe, and who should avoid it?

Bee venom therapy carries a meaningful safety risk for anyone with Hymenoptera venom allergy, mastocytosis, cardiovascular disease, or coagulation disorders. Anaphylaxis can occur even in individuals with no prior allergic history, and sessions should only be conducted where epinephrine is immediately available. Pregnant women, individuals on anticoagulants, and immunocompromised patients should avoid bee venom therapy altogether.

### What is the difference between bee venom therapy and bee venom acupuncture?

Bee venom therapy (BVT) is a broad term encompassing direct bee stings, topical creams, injections, and acupuncture-point delivery of venom, while bee venom acupuncture (BVA) specifically refers to injecting diluted, pharmacologically standardized venom at Traditional Chinese Medicine acupoints using a syringe. BVA allows more controlled dosing—typically 0.1–1.0 mg of lyophilized venom per session—whereas direct stings deliver an uncontrolled bolus of approximately 50–140 µg of venom per sting.

### Does bee venom have anti-cancer properties?

Preclinical in vitro and animal studies have demonstrated that melittin induces apoptosis in several cancer cell lines, including breast, lung, and liver cancer cells, primarily by disrupting mitochondrial membrane potential and activating caspase-3/caspase-9 pathways. However, no human clinical trials have established anti-tumor efficacy, and systemic delivery of melittin at cytotoxic concentrations is highly toxic to normal cells, making therapeutic translation a significant ongoing challenge.

### What forms of bee venom are available as supplements, and how do they differ?

Bee venom supplements are available in several forms including freeze-dried powder, liquid extracts, topical creams, and injectable preparations used in apitherapy clinics. Freeze-dried powder offers standardized melittin content and longer shelf stability, while topical creams may contain lower bioactive concentrations suited for localized application. Injectable bee venom is typically administered by trained practitioners and delivers the full complement of bioactive peptides directly into tissues or acupuncture points.

### Does bee venom interact with common medications or blood thinners?

Bee venom may theoretically interact with anticoagulants and antiplatelet medications due to its phospholipase A2 component, which affects cell membrane integrity and inflammatory pathways. There is limited clinical data on specific drug interactions, but individuals taking warfarin, aspirin, or other blood-thinning medications should consult a healthcare provider before using bee venom supplements. Additionally, bee venom's immunomodulatory effects warrant caution if combined with immunosuppressant medications.

### What does current clinical research actually show about bee venom's effectiveness?

Most current research focuses on the biochemical characterization of bee venom components (melittin, phospholipase A2, apamin) rather than robust clinical trials demonstrating therapeutic efficacy in humans. While in vitro and animal studies show promise for anti-inflammatory and analgesic properties, the evidence base for human supplementation remains limited, with many claims outpacing available clinical data. High-quality, large-scale human trials are needed to establish definitive efficacy for specific health conditions.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*